Cosmos Health Inc
Filed Dec 18, 2024.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Dec 18, 2024
Contents
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Certain information included in this prospectus may be deemed to be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. Forward-looking statements are often characterized by the use of forward-looking terminology such as “may,” “will,” “expect,” “anticipate,” “estimate,” “continue,” “believe,” “should,” “intend,” “project” or other similar words, but are not the only way these statements are identified.
| · | our ability to raise capital when needed; |
| · | difficulties or delays in the product development process, including the results of preclinical studies or clinical trials; |
| · | ability to enter into financing and strategic agreements and relationships; |
| · | difficulties or delays in the regulatory approval process; |
| · | adverse side effects or inadequate therapeutic efficacy of our drug candidates that could slow or prevent product development or commercialization; |
| · | dependence on third party suppliers; |
| · | uncertainties relating to manufacturing, sales, marketing and distribution of our drug candidates that may be successfully developed and approved for commercialization; |
| · | the uncertainty of protection for our patents and other intellectual property or trade secrets; |
| · | competition; |
| · | potential adverse effects resulting from failure to maintain effective internal controls; |
| · | the potential volatility of the market price for our shares of Common Stock; |
| · | the potential dilution of our shareholders’ potential ownership due to this offering and future issuances of share capital; |
| · | our ability to comply with the applicable continued listing requirements of Nasdaq; and |
| · | other factors referred to in section “Risk Factors” in this prospectus. |
All forward-looking statements contained herein speak only as of the date of this prospectus and are expressly qualified in their entirety by the cautionary statements included in this prospectus. We do not undertake to update or revise forward-looking statements to reflect events or circumstances that arise after the date on which such statements are made or to reflect the occurrence of unanticipated events, except as required by law. In evaluating forward-looking statements, you should consider these risks and uncertainties and not place undue reliance on our forward-looking statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.